Literature DB >> 34804350

Fibrous Proliferations in Posttransplant Kaposi Sarcoma.

Kevin M Adams1,2, Philip Milam1,2, Alejandro Gru1,2, Benjamin H Kaffenberger1,2.   

Abstract

Kaposi sarcoma (KS) is characterized by cutaneous lesions that are often papular and present variably depending on the stage of progression. We describe a patient with a fibroma-like nodule, a lesion not commonly associated with KS. Previously observed in lymphedematous human immunodeficiency virus-associated KS, the occurrence of this nodule in the absence of chronic lymphedema suggests an alternative etiology.
Copyright © 2021. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  CD34; Kaposi sarcoma; Kaposi’s sarcoma; Kaposi’s sarcoma-associated fibroma; fibroma; fibroma-like nodule; fibroma-like proliferation; fibrous proliferation; human herpesvirus-8

Year:  2021        PMID： 34804350      PMCID： PMC8594533     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


  10 in total

1.  Lymphedematous HIV-associated Kaposi's sarcoma.

Authors:  Pratistadevi K Ramdial; Runjan Chetty; Bhugwan Singh; Rajendrakumar Singh; Jamila Aboobaker
Journal:  J Cutan Pathol       Date:  2006-07       Impact factor: 1.587

2.  Infection of circulating CD34+ cells by HHV-8 in patients with Kaposi's sarcoma.

Authors:  M Henry; A Uthman; A Geusau; A Rieger; L Furci; A Lazzarin; P Lusso; E Tschachler
Journal:  J Invest Dermatol       Date:  1999-10       Impact factor: 8.551

3.  Cellular digital fibromas: distinctive CD34-positive lesions that may mimic dermatofibrosarcoma protuberans.

Authors:  Jennifer M McNiff; Antonio Subtil; Shawn E Cowper; Rossitza Lazova; Earl J Glusac
Journal:  J Cutan Pathol       Date:  2005-07       Impact factor: 1.587

4.  Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.

Authors:  N J Bodsworth; M Bloch; M Bower; D Donnell; R Yocum
Journal:  Am J Clin Dermatol       Date:  2001       Impact factor: 7.403

5.  Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development.

Authors:  Pawan Pyakurel; Fatemeh Pak; Amos R Mwakigonja; Ephata Kaaya; Thomas Heiden; Peter Biberfeld
Journal:  Int J Cancer       Date:  2006-09-15       Impact factor: 7.396

6.  Human herpesvirus-8 latent nuclear antigen-1 expression in endemic Kaposi sarcoma: an immunohistochemical study of 16 cases.

Authors:  Erich J Schwartz; Ronald F Dorfman; Sabine Kohler
Journal:  Am J Surg Pathol       Date:  2003-12       Impact factor: 6.394

7.  Evaluation of effectiveness of cryotherapy on the treatment of cutaneous Kaposi's sarcoma.

Authors:  Zekayi Kutlubay; Murat Küçüktaş; Gürkan Yardımcı; Burhan Engin; Server Serdaroğlu
Journal:  Dermatol Surg       Date:  2013-07-23       Impact factor: 3.398

8.  Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trial.

Authors:  J W Tappero; T G Berger; L D Kaplan; P A Volberding; J O Kahn
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

Review 9.  The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma.

Authors:  Silvia Gramolelli; Thomas F Schulz
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

Review 10.  Concise review: evidence for CD34 as a common marker for diverse progenitors.

Authors:  Laura E Sidney; Matthew J Branch; Siobhán E Dunphy; Harminder S Dua; Andrew Hopkinson
Journal:  Stem Cells       Date:  2014-06       Impact factor: 6.277
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.